Advanced Cell Technology Names the Chairman of the Board
Board of Directors Vote Unanimously to Expand CEO’s Role with Appointment as Chairman
Advanced Cell Technology (ACTC), Inc., applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that Chief Executive Officer William Caldwell IV has been appointed to serve as the Chairman of the Board in a unanimous vote by the Company’s directors.
Mr. Caldwell will assume the role of Chairman from Dr. Michael D. West, who will remain President and Chief Scientific Officer of Advanced Cell Technology. Dr. West, a recognized leader in the fields of embryonic stem cell science and regenerative medicine, will now focus his 100 percent of his duties on ACTC’s scientific programs.
“I want to thank Dr. West for his leadership at Advanced Cell Technology during his service as Chairman of the Board. We are all grateful for his current and continuing contributions,” said Mr. Caldwell. “My role as CEO with ACTC’s business and scientific teams has been extremely rewarding, and I welcome the Board’s support in their decision to expand my duties in the position of Chairman.”
By Advanced Cell Technology
